Increased NF-κB activity and the ensuing inflammation contribute to the dysregulation of insulin signaling at peripheral sites, like the liver [9,13,14,16], perpetuating NAFLD. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.